New HEDS Discussion Paper - Explaining national differences in the mortality of Covid-19: Individual patient simulation model to investigate the effects of testing policy and other factors on apparent mortality

Explaining national differences in the mortality of Covid-19: Individual patient simulation model to investigate the effects of testing policy and other factors on apparent mortality

Jonathan A Michaels, Matt D Stevenson

Abstract

Professor Jonathan Michaels    

There has been extensive speculation on the apparent differences in mortality between countries reporting on the confirmed cases and deaths due to Covid-19. A number of explanations have been suggested, but there is no clear evidence about how apparent fatality rates may be expected to vary with the different testing regimes, admission policies and other variables. An individual patient simulation model was developed to address this question. Parameters and sensitivity analysis based upon recent international data sources for Covid-19 and results were averaged over 100 iterations for a simulated cohort of over 500,000 patients.

Different testing regimes for Covid-19 were considered; testing admitted patients only, various rates of community testing of symptomatic cases and active contact-tracing and screening.

Professor Matt
Stevenson

In the base case analysis, apparent mortality ranged from 10.5% under a policy of testing only admitted patients to 0.4% with intensive contact tracing and community testing. These findings were sensitive to assumptions regarding admission rates and the rate of spread, with more selective admission policies and suppression of spread increasing the apparent mortality and the potential for apparent mortality rates to exceed 18% under some circumstances. Under all scenarios the proportion of patients tested in the community had the greatest impact on apparent mortality.

Whilst differences in mortality due to health service and demographic factors cannot be excluded, the current international differences in reported mortality are all consistent with differences in practice regarding screening, community testing and admission policies.

Download the Discussion Paper here

Business as usual for Online Learning from HEDS

With most UK universities moving their teaching online during the coronavirus outbreak, HEDS has a wealth of expertise as an experienced provider of online courses, making the transition for our face-to-face courses relatively straightforward.

Since 2011, HEDS has offered a fully online masters programme in the form of the MSc in International Health Technology Assessment and Reimbursement, and also offers two FREE online courses via Futurelearn- Measuring and Valuing Health, and Health Technology Assessment: Choosing which treatments get funded.

Image  © University of Sheffield 2020

Our online MSc, PG Diploma and PG Certificate programmes offer students the ability to study flexibly, over a 2-4 year period, fitting study in around work and other life commitments. Online learning is not simply face-to-face teaching, digitised. It's a completely different approach to delivering our expertise, using short-format video, audio, online tasks, discussions and access to a vast e-Library of books, databases and journals to support independent learning.

ScHARR has no less than 3 learning technologists whose role is to ensure our online teaching runs smoothly and takes advantage of new technologies as they emerge, ensuring our students have the most straightforward and engaging learning experience.

If you want to try online learning yourself, you can enrol on our FREE courses now. Both courses are available to register, and Health Technology Assessment: Choosing which treatments get funded starts its current ‘live’ run on Monday 30th March 2020. You’ll be learning from world-leading experts in an accessible and enjoyable way, and it might just make you wonder how far online learning could take you!